Crossmark

Development of an immunohistochemical assay for Siglec-15

Crossref DOI link: https://doi.org/10.1038/s41374-022-00785-9

Published Print: 2022-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Shafi, Saba

Aung, Thazin Nwe https://orcid.org/0000-0003-4150-0426
Robbins, Charles

Zugazagoitia, Jon

Vathiotis, Ioannis

Gavrielatou, Niki

Yaghoobi, Vesal

Fernandez, Aileen

Niu, Shuqiong

Liu, Linda N.

Cusumano, Zachary T.

Leelatian, Nalin

Cole, Kimberley

Wang, He

Homer, Robert https://orcid.org/0000-0002-2055-5885
Herbst, Roy S.

Langermann, Sol

Rimm, David L. https://orcid.org/0000-0001-5820-4397
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50 CA196530)

NextCure
License Information

Text and Data Mining valid from 2022-07-01

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2023-07-01
More Information

This article is maintained by: Elsevier

Article Title: Development of an immunohistochemical assay for Siglec-15

Journal Title: Laboratory Investigation

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41374-022-00785-9

Content Type: article

Copyright: © 2022 United States & Canadian Academy of Pathology.